Early peanut introduction linked to big drop in childhood food allergy diagnoses, CHOP study shows
A 2025 Children’s Hospital of Philadelphia study, published in Pediatrics, found early peanut introduction to infants coincided with a 27% drop in peanut allergy diagnoses and roughly a 36–38% decline in overall childhood IgE-mediated food allergies across U.S. pediatric records.
Key takeaways
- Large observational analysis: CHOP reviewed electronic records for more than 120,000 children across dozens of U.S. pediatric practices — and observed population-level declines in allergy diagnoses.
- Measured declines: ~27% fewer peanut allergy diagnoses and a ~36–38% reduction in overall IgE-mediated food allergies after the 2017 guidance change.
- Real-world support for early introduction: Findings align with clinical trials like LEAP and suggest NIAID’s 2017 recommendations are affecting outcomes.
- Caveats: Observational design, data ending in early 2019, and limited feeding-history detail mean association ≠ proven causation.
What the CHOP study found
The Children’s Hospital of Philadelphia team analyzed electronic medical records from more than 120,000 children seen at dozens of pediatric practices across the United States. They compared trends before and after 2017, when the National Institute of Allergy and Infectious Diseases updated its guidance to recommend early peanut introduction — as early as 4 to 11 months for some infants, replacing earlier advice to avoid peanuts for years. The researchers reported a 27% decrease in peanut allergy diagnoses and around a 36–38% drop in overall food allergy diagnoses after the guideline change (CHOP news release; Fox News coverage).
Why early exposure appears to work
Researchers propose that early oral exposure trains a baby’s immune system to tolerate peanut protein via the gut, reducing misdirected immune responses later. This mechanism is consistent with randomized trials — notably the 2015 LEAP study, which reported an 81% reduction in peanut allergy risk for high-risk infants who consumed peanut products early and regularly. CHOP’s analysis offers real-world evidence that the guideline may be shifting allergy rates at population scale (CHOP news release; National Peanut Board summary).
How the findings fit with past guidance
Before 2015 many clinicians advised delaying peanut introduction until age 3 or older. After clinical trials, the NIAID officially updated guidance in 2017 to encourage early introduction for many infants; that guidance expanded in 2021 to include multiple allergens. CHOP examined early uptake after 2017 and found a meaningful decline in diagnoses, suggesting practice patterns shifted in response to new recommendations (ACAAI summary; Fox News coverage).
Expert reaction and public health perspective
Authors and specialists welcomed the results while urging careful messaging. First author Stanislaw Gabryszewski, M.D., Ph.D., and colleagues called the results the strongest real-world evidence yet that updated guidance is altering allergy trajectories (CHOP news release). Cherie Zachary, M.D., then-president of the American College of Allergy, Asthma & Immunology, described the findings as promising and consistent with prior trial evidence (ACAAI statement).
Public-health groups and industry advocates labeled the study “real-world evidence” of benefit, while other clinicians noted uneven adoption of guidance and the need for more education and training (National Peanut Board; Lurie Children’s report).
Limitations and questions that remain
The CHOP analysis is observational: it identifies associations, not causal proof. The study used electronic health record diagnoses and lacked individual feeding histories, so investigators could not confirm which infants consumed peanuts or exactly when. Data end in early 2019, before 2021 guidance broadening early introduction to more allergens — so later trends are not captured (Fox News summary; Allergic Living critique).
Experts also question whether reductions in non-peanut allergies can be attributed to early peanut introduction alone. Shifts in leading allergens (for example, eggs overtaking peanuts in some reports) indicate multiple factors likely influence changing patterns (ACAAI summary).
Safety and practical advice for parents
Public health messages highlight safety: do not give whole peanuts to infants (choking risk). Recommended forms include smooth peanut butter thinned with water, peanut-containing puffs or cereals, and other age-appropriate products. Parents should consult their pediatrician, especially if a baby has severe eczema or a prior egg allergy; those infants may need allergy testing or supervised in-clinic introduction. In suspected severe reactions, seek emergency care and epinephrine treatment immediately (Fox News; ACAAI guidance).
Training tools for pediatricians are emerging to help clinicians follow guidance and coach parents on safe early feeding, which could increase real-world benefits (Northwestern news).
Implications for Paso Robles, California
Local parents and pediatricians in Paso Robles can act on the evidence while prioritizing safety. Practical steps include:
- For families: Discuss early peanut introduction with your child’s pediatrician. Ask about supervised introduction or testing if your infant has severe eczema or prior allergic reactions. Use safe forms of peanut rather than whole nuts (ACAAI guidance).
- For local pediatricians and clinics: Review NIAID guidance and consider standardizing counseling, timing (often around 4–6 months for many infants), and follow-up; training can help staff counsel caregivers effectively (CHOP news release; Northwestern report).
- For schools and daycares: Balance allergy safety with prevention; consult public-health guidance and pediatric specialists when creating food policies and emergency plans.
- For conservative families: Use evidence-based discussion with clinicians to weigh risks and benefits and make informed choices for your child (National Peanut Board).
Where to read more and verify sources
- CHOP news release
- Fox News summary
- ACAAI statement
- National Peanut Board
- Lurie Children’s report on parental confusion
- Allergic Living critique
- Northwestern on training tools for pediatricians
- JAMA Network discussion of barriers and implementation
- Public health review on multi-allergen guidance and longer-term evidence
Bottom line: CHOP’s large-scale observational analysis provides encouraging real-world evidence that early peanut introduction — consistent with NIAID guidance — is associated with substantial drops in peanut and overall IgE-mediated food allergy diagnoses, while underscoring the need for careful implementation and additional study.
